BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24220173)

  • 1. Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors.
    Komloova M; Horova A; Hrabinova M; Jun D; Dolezal M; Vinsova J; Kuca K; Musilek K
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6663-6. PubMed ID: 24220173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
    Komloova M; Musilek K; Horova A; Holas O; Dohnal V; Gunn-Moore F; Kuca K
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2505-9. PubMed ID: 21397501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, in vitro screening and molecular modelling of monoquaternary compounds related to the selective acetylcholinesterase inhibitor BW284c51.
    Benek O; Musilek K; Horova A; Dohnal V; Dolezal R; Kuca K
    Med Chem; 2014; 11(1):21-9. PubMed ID: 24773345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatment.
    Musilek K; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K
    Eur J Med Chem; 2011 Feb; 46(2):811-8. PubMed ID: 21236521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
    Musilek K; Komloova M; Zavadova V; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K; Jung YS
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1763-6. PubMed ID: 20138518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does "butyrylization" of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase?
    Kaplan D; Ordentlich A; Barak D; Ariel N; Kronman C; Velan B; Shafferman A
    Biochemistry; 2001 Jun; 40(25):7433-45. PubMed ID: 11412096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are simultaneous reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by nerve agent surrogates.
    Lee HM; Andrys R; Jonczyk J; Kim K; Vishakantegowda AG; Malinak D; Skarka A; Schmidt M; Vaskova M; Latka K; Bajda M; Jung YS; Malawska B; Musilek K
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):437-449. PubMed ID: 33467931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, in vitro screening and molecular modelling of symmetrical 4-tert-butylpyridinium cholinesterase inhibitors--analogues of SAD-128.
    Musilek K; Roder J; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Opletalova V; Kuca K; Jung YS
    Bioorg Med Chem Lett; 2011 Jan; 21(1):150-4. PubMed ID: 21144749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of a complex of the potent and specific inhibitor BW284C51 with Torpedo californica acetylcholinesterase.
    Felder CE; Harel M; Silman I; Sussman JL
    Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1765-71. PubMed ID: 12351819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
    Huang L; Luo Z; He F; Lu J; Li X
    Bioorg Med Chem; 2010 Jun; 18(12):4475-84. PubMed ID: 20471843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acetylcholinesterase and butyrylcholinesterase in mouse skeletal muscle. Specificity of irreversible inhibition by an organophosphorus compound of the methylphosphorothiolate type and multiple molecular forms].
    Goudou D; Friboulet A; Dreyfus P; Rieger F
    C R Seances Acad Sci III; 1983 Jan; 296(4):169-72. PubMed ID: 6405980
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
    Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
    Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
    Vafadarnejad F; Mahdavi M; Karimpour-Razkenari E; Edraki N; Sameem B; Khanavi M; Saeedi M; Akbarzadeh T
    Bioorg Chem; 2018 Apr; 77():311-319. PubMed ID: 29421707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid residues controlling reactivation of organophosphonyl conjugates of acetylcholinesterase by mono- and bisquaternary oximes.
    Ashani Y; Radić Z; Tsigelny I; Vellom DC; Pickering NA; Quinn DM; Doctor BP; Taylor P
    J Biol Chem; 1995 Mar; 270(11):6370-80. PubMed ID: 7890775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors.
    Wang C; Wu Z; Cai H; Xu S; Liu J; Jiang J; Yao H; Wu X; Xu J
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5212-6. PubMed ID: 26454504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, biological evaluation and docking study of 5-oxo-4,5-dihydropyrano[3,2-c]chromene derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Khoobi M; Alipour M; Sakhteman A; Nadri H; Moradi A; Ghandi M; Emami S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2013 Oct; 68():260-9. PubMed ID: 23988409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel coumarin derivatives bearing N-benzyl pyridinium moiety: potent and dual binding site acetylcholinesterase inhibitors.
    Alipour M; Khoobi M; Foroumadi A; Nadri H; Moradi A; Sakhteman A; Ghandi M; Shafiee A
    Bioorg Med Chem; 2012 Dec; 20(24):7214-22. PubMed ID: 23140986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis.
    Harel M; Sussman JL; Krejci E; Bon S; Chanal P; Massoulié J; Silman I
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10827-31. PubMed ID: 1438284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histochemical demonstration of acetylcholinesterase activity in human Meibomian glands.
    Perra MT; Serra A; Sirigu P; Turno F
    Eur J Histochem; 1996; 40(1):39-44. PubMed ID: 8741098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
    Korabecny J; Musilek K; Holas O; Binder J; Zemek F; Marek J; Pohanka M; Opletalova V; Dohnal V; Kuca K
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6093-5. PubMed ID: 20817518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.